Solutions

Online Inquiry

Global Services. (Creative Biolabs Authorized)

Cytokine & Biomarker Profiling (IL-6, Ferritin, CRP) Service for CAR-T Development

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Accurately predicting patient response and managing adverse events like CRS remain significant challenges in CAR-T cell therapy development. Creative Biolabs' Cytokine & Biomarker Profiling Service for CAR-T Development delivers a targeted solution. We provide precise, high-sensitivity quantification of key markers, IL-6, Ferritin, and CRP, to monitor immune activation and endothelial stress. The key advantage is the generation of actionable, regulatory-ready data that enables clients to proactively identify toxicity risks, correlate biomarkers with clinical outcomes, and optimize dosing and patient management strategies for safer, more effective therapies.

Introduction

Pre-treatment systemic inflammation, as reflected by elevated IL-6, Ferritin, and CRP, poses a significant barrier to durable efficacy and safety in CAR-T therapy for relapsed/refractory multiple myeloma. This study establishes a strong correlation between elevated pre-infusion levels of these biomarkers and adverse clinical outcomes, including reduced progression-free survival, overall survival, and an increased risk for severe cytokine release syndrome.

Fig.1 Inflammatory markers in relation to CRS. (OA Literature) Fig.1 Connections between inflammatory markers and CRS development.¹

Cytokine & Biomarker Profiling (IL-6, Ferritin, CRP) Service for CAR-T Development at Creative Biolabs

Creative Biolabs provides the analytical rigor required to transform raw biological data into actionable clinical insights. By profiling critical drivers of inflammation and endothelial activation, we enable developers to identify therapeutic windows and safety thresholds early in the development cycle. Our service directly addresses the complexities of "cytokine storms" by correlating IL-6 spikes with systemic markers like Ferritin and CRP, ensuring a multidimensional view of the immune response.

What We Can Offer

We offer integrated cytokine and biomarker profiling services that leverage precise longitudinal monitoring, multiplex analysis, and advanced platforms to predict and manage CAR-T therapy toxicities like CRS/ICANS.

Featured services of cytokine & biomarker profiling service for CAR-T development at Creative Biolabs. (Creative Biolabs Original)

Our Service Process

Required Starting Materials:

Sample Matrix: longitudinal serum, plasma, or cerebrospinal fluid (CSF) samples.
Project Specifications: Baseline clinical data or pre-clinical model parameters (e.g., cell dose, tumor burden).
Target Profile: Specific cytokine panels of interest.

Key Steps:

Workflow of cytokine & biomarker profiling service for CAR-T development at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

Comprehensive Analytical Report: A detailed document containing raw data, normalized concentrations, and statistical significance.
Interactive Visualization: Kinetic plots of IL-6, CRP, and Ferritin levels over the study duration.

Key Advantages

Customizable, High-Efficiency Assay Development: Our team excels in rapidly developing highly tailored analytical panels that extend beyond standard cytokine biomarkers like IL-6, CRP, and Ferritin.
Assured Biomarker Integrity: We guarantee analyte stability through optimized sample handling protocols and rigorously verified cold-chain logistics.
Fully Flexible, Expert-Driven Customization: Our service modules are fully adaptable, allowing our biology specialists to fine-tune parameters such as signal detection or assay sensitivity to meet your project's unique objectives.

FAQs

Q1: Why is Ferritin included in your CAR-T profiling panel?

A1: Ferritin is a key acute-phase reactant. High levels are strongly correlated with the severity of CRS and macrophage activation, providing a necessary layer of data beyond simple cytokine counts.

Q2: Can you process samples from mouse models?

A2: Yes, we offer cross-species profiling, including validated panels for murine IL-6 and other inflammatory markers suitable for pre-clinical CAR-T research.

Q3: How does your service compare to standard ELISA kits?

A3: Our multiplex approach requires significantly less sample volume and provides a broader dynamic range, which is essential for the extreme concentration spikes seen in CAR-T patients.

Why Choose Us?

We provide cytokine & biomarker profiling uniquely engineered for the challenges of CAR-T development. By integrating established assays for IL-6, CRP, and Ferritin with advanced risk scores, we deliver actionable insights into immune activation, toxicity, and endothelial health with superior predictive value for clinical decision-making.

Customer Reviews

"Implementing the CRP scoring via Creative Biolabs facilitated a much clearer comparison between our novel CAR-T construct and existing benchmarks. A vital service for any safety-first pipeline."

— R***rt Chen.

"Using Creative Biolabs' profiling in our research has significantly facilitated the identification of high-risk patients before the onset of clinical symptoms. The integration of CRP and Ferritin kinetics was far more informative than IL-6 alone."

— J***n Doe.

"The multiplex cytokine analysis significantly improved our ability to detect low-level IL-6 fluctuations in early-stage CAR-T models. The data was clean, reproducible, and ready for publication."

— Dr. A***a Smith.

How to contact us?

For a comprehensive analysis of key CAR-T biomarkers like IL-6, Ferritin, and CRP to correlate with therapy response and toxicity, contact us today. Our expert technical team is ready to discuss your specific needs and provide a customized project quote to accelerate your development timeline.

Reference

Liu, Yang et al. "A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells." Frontiers in immunology vol. 14 1169071. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2023.1169071

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.